Yahoo España Búsqueda web

  1. Anuncio

    relacionado con: jim cramer 3 stocks
  2. Using their trading system, Zacks experts give you their prediction for A in free RPT. Should you pass or buy Agilent? Zacks experts tell all in a a new free Special Report.

Search results

  1. Hace 5 días · Jim Cramer recommended several stocks in his latest programs aired on CNBC. We watched these programs and picked 5 stocks for this article that he either recommended investors to buy or...

  2. Hace 3 días · GigaCloud Technology Inc (NASDAQ:GCT) ranks sixth on Insider Monkey’s list titled Jim Cramer Says You Should Stay Away from These 7 Stocks. Let’s take a detailed look at why Cramer is bearish ...

  3. Hace 5 días · Jim Cramers top 10 things to watch in the stock market Wednesday. Published Wed, May 22 20249:27 AM EDT. Jim Cramer @jimcramer. My top 10 things to watch Wednesday, May 22. Nvidia earnings...

  4. Hace 5 días · Mad Money with Jim Cramer. “Mad Money” takes viewers inside the mind of one of Wall Street’s most respected and successful money managers for free. Cramer is listeners’ personal guide ...

  5. Hace 3 días · Jim Cramer sees 'green shoot' in stock market reaction to this secondary stock sale. The market reaction to a $300 million secondary stock offering from Dutch Bros (BROS) is an encouraging sign, CNBC's Jim Cramer said.

  6. Hace 4 días · Merit Medical Systems, Inc. (NASDAQ:MMSI) is “good,” Cramer said. On April 30, Merit Medical Systems posted upbeat results for the first quarter. Price Action: Corning shares gained 0.3% to settle at $36.58 on Wednesday. Axon shares fell 1.1% to close at $284.87 on Wednesday. Recursion Pharmaceuticals shares slipped 1.6% to settle at $9.36.

  7. Hace 4 días · On CNBC's “Mad Money Lightning Round,” Jim Cramer said Recursion Pharmaceuticals, Inc. RXRX is a “terrific spec” and he recommended buying the same.

  1. Anuncio

    relacionado con: jim cramer 3 stocks
  2. Using their trading system, Zacks experts give you their prediction for A in free RPT. Should you pass or buy Agilent? Zacks experts tell all in a a new free Special Report.